M. Bensaid

发表

The Canadian Consortium for the Investigation of Cannabinoids in Human Therapeutics

B. Scatton, F. Oury-Donat, G. Le Fur, 2022 .

Rimonabant reduces obesity‐associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

P. Soubrié, B. Scatton, F. Oury-Donat, 2007, Hepatology.

The Cannabinoid CB 1 Receptor Antagonist Rimonabant ( SR 141716 ) Inhibits Cell Proliferation and Increases Markers of Adipocyte Maturation in Cultured Mouse 3 T 3 F 442 A Preadipocytes

B. Scatton, F. Oury-Donat, G. Fur, 2006 .

Antithrombotic, Antiaggregant and Anticoagulant Effect of Methanolic Fraction of Calamintha officinalis: In vitro and ex vivo Experiments

A. Ziyyat, M. Berrabah, M. Bensaid, 2018, Journal of Natural Remedies.

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells.

P. Soubrié, F. Oury-Donat, J. Maffrand, 2003, Molecular pharmacology.

Expression of tachykinin NK2 receptor mRNA in human brain

P. Soubrié, E. Hirsch, Y. Agid, 2001, Neuroscience Letters.

Expression and presence of septal neurokinin‐2 receptors controlling hippocampal acetylcholine release during sensory stimulation in rat

P. Soubrié, R. Steinberg, F. Oury-Donat, 1998, The European journal of neuroscience.

Purification and Characterization of the Human SR 31747A-binding Protein

S. Galiègue, P. Casellas, P. Ferrara, 1997, The Journal of Biological Chemistry.